Advertisement

Pharmacy

A bipartisan Senate bill designed to stop drug companies from manipulating the patent system to block cheaper competitors from the market has been stalled in the debate over drug prices, according to Politico.

Advertisement

An FDA advisory panel recommended the agency remove Makena, a treatment for preventing preterm births, from the market after reviewing data that shows it may not be effective, according to STAT. 

In a setback for Novartis' efforts to expand the use of its gene therapy drug Zolgensma to older patients, the FDA halted the drugmaker's clinical trial after it found a safety concern in an animal study, according to STAT.

Advertisement